Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 1801585
Publisher
Wiley
Online
2018-12-12
DOI
10.1002/advs.201801585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Responses in the Liver
- (2018) Paul Kubes et al. Annual Review of Immunology
- Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
- (2018) Juan Pablo Arab et al. Annual Review of Pathology-Mechanisms of Disease
- Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
- (2018) Julia Wattacheril et al. Annual Review of Pharmacology and Toxicology
- TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue
- (2018) Peng Zhao et al. CELL
- Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
- (2018) Varman T. Samuel et al. Cell Metabolism
- Time to step-up the fight against NAFLD
- (2018) Xiao-Jing Zhang et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis
- (2018) Alexander J. Kovalic et al. Hepatology International
- Dusp14 protects against hepatic ischaemia–reperfusion injury via Tak1 suppression
- (2018) Xiaozhan Wang et al. JOURNAL OF HEPATOLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study
- (2018) S. Harrison et al. JOURNAL OF HEPATOLOGY
- The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
- (2018) Marie Boyle et al. JOURNAL OF HEPATOLOGY
- Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
- (2018) Rohit Loomba JOURNAL OF HEPATOLOGY
- Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1
- (2018) Juan-Juan Qin et al. JOURNAL OF HEPATOLOGY
- Determinants of fibrosis progression and regression in NASH
- (2018) Detlef Schuppan et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Preclinical models of non-alcoholic fatty liver disease
- (2018) Prasanna K. Santhekadur et al. JOURNAL OF HEPATOLOGY
- Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
- (2018) Thomas Jensen et al. JOURNAL OF HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
- (2018) Ana Ruth Araújo et al. LIVER INTERNATIONAL
- The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
- (2018) Yan-Xiao Ji et al. NATURE MEDICINE
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD
- (2018) Elliot B. Tapper et al. Nature Reviews Gastroenterology & Hepatology
- Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
- (2018) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
- (2018) Vincent Wai-Sun Wong et al. Nature Reviews Gastroenterology & Hepatology
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
- (2018) Christopher D Byrne et al. BMJ-British Medical Journal
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
- (2018) Christopher D Byrne et al. BMJ-British Medical Journal
- Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease
- (2018) Jingjing Cai et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation
- (2017) David Goldberg et al. GASTROENTEROLOGY
- The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis
- (2017) Feng-Juan Yan et al. HEPATOLOGY
- USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity
- (2017) Shimin An et al. HEPATOLOGY
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance
- (2017) Quan-Yu Zhang et al. HEPATOLOGY
- Reprogramming Innate Immune Signaling in Cardiometabolic Disease
- (2017) Yaxing Zhang et al. HYPERTENSION
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury
- (2017) Xiao-Jing Zhang et al. NATURE MEDICINE
- Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
- (2017) Pi-Xiao Wang et al. NATURE MEDICINE
- The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
- (2017) Peng Zhang et al. NATURE MEDICINE
- Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
- (2017) Guang-Nian Zhao et al. NATURE MEDICINE
- Endocrine-disrupting chemicals and fatty liver disease
- (2017) Charles E. Foulds et al. Nature Reviews Endocrinology
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- (2017) Anna M. Diehl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatty liver promotes fibrosis in monkeys consuming high fructose
- (2017) Michael A. Cydylo et al. Obesity
- Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases
- (2017) Yaxing Zhang et al. PHYSIOLOGY
- Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance
- (2017) Joonseok Cho et al. Nature Communications
- Epigenetics and Trained Immunity
- (2017) Charlotte D.C.C. van der Heijden et al. ANTIOXIDANTS & REDOX SIGNALING
- Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance
- (2016) Pengcheng Luo et al. AMERICAN JOURNAL OF PATHOLOGY
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
- (2016) Joel T. Haas et al. Annual Review of Physiology
- Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites
- (2016) You Zhou et al. Clinical Gastroenterology and Hepatology
- Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
- (2016) Quentin M. Anstee et al. GASTROENTEROLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: A growing epidemic
- (2016) Rachel Abou Mrad et al. HEPATOLOGY
- Liver capsule: IRFs in hepatocytes: Pathophysiology
- (2016) Pi-Xiao Wang et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Gut Microbiota and Lifestyle Interventions in NAFLD
- (2016) David Houghton et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis
- (2016) Ling Gao et al. JOURNAL OF HEPATOLOGY
- Sitagliptin Versus Placebo in the Treatment of Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
- (2016) J.Y. Cui et al. JOURNAL OF HEPATOLOGY
- Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
- (2016) Mei Xiang et al. JOURNAL OF HEPATOLOGY
- DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity
- (2016) Lanfeng Xie et al. JOURNAL OF HEPATOLOGY
- Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury
- (2016) Junfei Hu et al. JOURNAL OF HEPATOLOGY
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Signals from the gut microbiota to distant organs in physiology and disease
- (2016) Bjoern O Schroeder et al. NATURE MEDICINE
- Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
- (2016) Giovanni Musso et al. NATURE REVIEWS DRUG DISCOVERY
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Endoplasmic reticulum proteostasis in hepatic steatosis
- (2016) Andrei Baiceanu et al. Nature Reviews Endocrinology
- NAFLD and diabetes mellitus
- (2016) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Developmental origins of NAFLD: a womb with a clue
- (2016) Stephanie R. Wesolowski et al. Nature Reviews Gastroenterology & Hepatology
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- Management of NAFLD: a stage-based approach
- (2016) Mary E. Rinella et al. Nature Reviews Gastroenterology & Hepatology
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- (2016) Obesity Facts
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
- (2016) Pi-Xiao Wang et al. Nature Communications
- The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
- (2016) Yan-Xiao Ji et al. Nature Communications
- Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
- (2016) Ke-Qiong Deng et al. Nature Communications
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
- (2015) I. Doycheva et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy
- (2015) Jeremy Lok Wei et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis
- (2015) Andrew A. Pierce et al. BMC GASTROENTEROLOGY
- The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases
- (2015) Xiao-Jing Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-alcoholic fatty liver disease following liver transplantation: a clinical review
- (2015) Jonathan Merola et al. CLINICAL TRANSPLANTATION
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Zebrafish: An Important Tool for Liver Disease Research
- (2015) Wolfram Goessling et al. GASTROENTEROLOGY
- Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
- (2015) Paola Dongiovanni et al. HEPATOLOGY
- Tumor Necrosis Factor Receptor–Associated Factor 3 Is a Positive Regulator of Pathological Cardiac HypertrophyNovelty and Significance
- (2015) Xi Jiang et al. HYPERTENSION
- Interferon Regulatory Factor Signalings in Cardiometabolic Diseases
- (2015) Xiao-Jing Zhang et al. HYPERTENSION
- The Cellular and Molecular Basis of Translational Immunometabolism
- (2015) Giuseppe Danilo Norata et al. IMMUNITY
- Hepatitis regulation by the inflammasome signaling pathway
- (2015) Amina A. Negash et al. IMMUNOLOGICAL REVIEWS
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mindin deficiency protects the liver against ischemia/reperfusion injury
- (2015) Peng Sun et al. JOURNAL OF HEPATOLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- LP37 : A placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases
- (2015) M. Shiffman et al. JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury
- (2015) Pi-Xiao Wang et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Leptin in nonalcoholic fatty liver disease: A narrative review
- (2015) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Caring for children with NAFLD and navigating their care into adulthood
- (2015) Ali A. Mencin et al. Nature Reviews Gastroenterology & Hepatology
- Prednisolone or Pentoxifylline for Alcoholic Hepatitis
- (2015) Mark R. Thursz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic fatty liver disease
- (2015) Elizabeth M. Brunt et al. Nature Reviews Disease Primers
- Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors
- (2014) N Gehrke et al. CELL DEATH AND DIFFERENTIATION
- Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
- (2014) Carlos J Pirola et al. GUT
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- The global burden of liver disease: The major impact of China
- (2014) Fu-Sheng Wang et al. HEPATOLOGY
- Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease
- (2014) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice
- (2014) Li-Hua Zhu et al. JOURNAL OF HEPATOLOGY
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Ubiquitination in disease pathogenesis and treatment
- (2014) Doris Popovic et al. NATURE MEDICINE
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
- (2014) H. Mahdessian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver
- (2014) Xiaomang Xing et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- TRAF1 is a key mediator for hepatic ischemia/reperfusion injury
- (2014) X-F Zhang et al. Cell Death & Disease
- TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
- (2014) Yang-Lin Liu et al. Nature Communications
- Interferon regulatory factor 9 is critical for neointima formation following vascular injury
- (2014) Shu-Min Zhang et al. Nature Communications
- IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling
- (2014) Ding-Sheng Jiang et al. Nature Communications
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
- (2013) E. Scorletti et al. Annual Review of Nutrition
- Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice
- (2013) Xin-An Wang et al. HEPATOLOGY
- Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance
- (2013) Xin-An Wang et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- Disruption of Tumor Necrosis Factor Receptor Associated Factor 5 Exacerbates Pressure Overload Cardiac Hypertrophy and Fibrosis
- (2013) Zhouyan Bian et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene
- (2013) Hwa-Li Tan et al. JOURNAL OF GASTROENTEROLOGY
- Epidemiology of alcoholic and nonalcoholic fatty liver disease in China
- (2013) Jian-Gao Fan JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- From NAFLD in clinical practice to answers from guidelines
- (2013) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- The liver diseases of lipodystrophy: The long-term effect of leptin treatment
- (2013) Elika Safar Zadeh et al. JOURNAL OF HEPATOLOGY
- Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction
- (2013) Lang Wang et al. JOURNAL OF NEUROCHEMISTRY
- Lifestyle intervention in childhood obesity: changes and challenges
- (2013) Thomas Reinehr Nature Reviews Endocrinology
- Noninvasive evaluation of NAFLD
- (2013) Laurent Castera et al. Nature Reviews Gastroenterology & Hepatology
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD in Asia—as common and important as in the West
- (2013) Geoffrey C. Farrell et al. Nature Reviews Gastroenterology & Hepatology
- From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
- (2013) Alexander Wree et al. Nature Reviews Gastroenterology & Hepatology
- The genetics of NAFLD
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Pharmacological agents for NASH
- (2013) Vlad Ratziu Nature Reviews Gastroenterology & Hepatology
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- TRAF1 is a critical regulator of cerebral ischaemia–reperfusion injury and neuronal death
- (2013) Yan-Yun Lu et al. Nature Communications
- Endoplasmic Reticulum Stress in Nonalcoholic Fatty Liver Disease
- (2012) Michael J. Pagliassotti Annual Review of Nutrition
- Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units
- (2012) Xiaona Hu et al. BMC GASTROENTEROLOGY
- Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
- (2012) Christopher K. Glass et al. Cell Metabolism
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
- (2012) Claudia O. Zein et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
- (2012) Carlo Pirazzi et al. JOURNAL OF HEPATOLOGY
- Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
- (2012) Mariana V. Machado et al. JOURNAL OF HEPATOLOGY
- Multigenerational epigenetic adaptation of the hepatic wound-healing response
- (2012) Müjdat Zeybel et al. NATURE MEDICINE
- Physical activity: an essential component of lifestyle modification in NAFLD
- (2012) Benjamin Rodriguez et al. Nature Reviews Gastroenterology & Hepatology
- Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach
- (2012) Anna Alisi et al. Nature Reviews Gastroenterology & Hepatology
- Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
- (2012) Enzo Bonora et al. Nature Reviews Gastroenterology & Hepatology
- Signaling in Innate Immunity and Inflammation
- (2012) K. Newton et al. Cold Spring Harbor Perspectives in Biology
- Pathogenesis of Liver Fibrosis
- (2011) Virginia Hernandez-Gea et al. Annual Review of Pathology-Mechanisms of Disease
- Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction
- (2011) Jinfeng Xiao et al. BASIC RESEARCH IN CARDIOLOGY
- Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
- (2011) Vincent Wai-Sun Wong et al. GUT
- Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
- (2011) Christer Baeck et al. GUT
- Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
- (2011) K. Hallsworth et al. GUT
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease
- (2011) Yongcheng Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease
- (2011) Leon A Adams et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
- (2011) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies
- (2011) Ahmad Al-Serri et al. JOURNAL OF HEPATOLOGY
- Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
- (2011) Christian Thoma et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment
- (2011) Briohny W. Smith et al. Nature Reviews Endocrinology
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease
- (2011) Ann K Daly et al. Expert Review of Gastroenterology & Hepatology
- Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Musso et al. Annual Review of Medicine
- Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
- (2010) Dina G. Tiniakos et al. Annual Review of Pathology-Mechanisms of Disease
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans
- (2010) Ronald J. A. Wanders et al. FEBS Journal
- Type I Interferons Protect From Toll-Like Receptor 9–Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice
- (2010) Jan Petrasek et al. GASTROENTEROLOGY
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
- (2010) S. McPherson et al. GUT
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
- (2010) Manal F. Abdelmalek et al. HEPATOLOGY
- Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease
- (2010) Kausik Das et al. HEPATOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease
- (2010) Perumal Nagarajan et al. LIVER INTERNATIONAL
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- Pathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M. Brunt Nature Reviews Gastroenterology & Hepatology
- Animal models of nonalcoholic fatty liver disease
- (2010) Lionel Hebbard et al. Nature Reviews Gastroenterology & Hepatology
- The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
- (2010) Jung Sub Lim et al. Nature Reviews Gastroenterology & Hepatology
- The role of the gut microbiota in nonalcoholic fatty liver disease
- (2010) Ahmed Abu-Shanab et al. Nature Reviews Gastroenterology & Hepatology
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic Fatty Liver Disease and Low-Carbohydrate Diets
- (2009) Linda Wasserbach York et al. Annual Review of Nutrition
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
- (2009) Anna Kotronen et al. GASTROENTEROLOGY
- Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine
- (2009) Lydia Lee et al. HEPATOLOGY
- Autophagy regulates lipid metabolism
- (2009) Rajat Singh et al. NATURE
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist
- (2008) Edward E. Cable et al. HEPATOLOGY
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
- Non-alcoholic fatty liver disease: The mist gradually clears
- (2008) Nimantha Mark Wilfred de Alwis et al. JOURNAL OF HEPATOLOGY
- Epidemiology of non-alcoholic fatty liver disease in China
- (2008) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Insulin resistance, inflammation, and non-alcoholic fatty liver disease
- (2008) Herbert Tilg et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now